MindBio Therapeutics (XCNQ:MBIO) Current Accrued Expense : C$0.00 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Current Accrued Expense?

MindBio Therapeutics's Current Accrued Expense for the quarter that ended in Mar. 2024 was C$0.00 Mil.

MindBio Therapeutics's quarterly Current Accrued Expense increased from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$0.04 Mil) but then declined from Dec. 2023 (C$0.04 Mil) to Mar. 2024 (C$0.00 Mil).

MindBio Therapeutics's annual Current Accrued Expense declined from Jun. 2021 (C$0.36 Mil) to Jun. 2022 (C$0.00 Mil) but then stayed the same from Jun. 2022 (C$0.00 Mil) to Jun. 2023 (C$0.00 Mil).

MindBio Therapeutics Current Accrued Expense Historical Data

The historical data trend for MindBio Therapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Current Accrued Expense Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Current Accrued Expense

0.36

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial					-	-	-	0.04	-

MindBio Therapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

MindBio Therapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.